Literature DB >> 18984791

Survival of dogs following surgical excision of histologically well-differentiated melanocytic neoplasms of the mucous membranes of the lips and oral cavity.

D G Esplin1.   

Abstract

Postsurgical follow-up information was obtained on 64 dogs with 69 histologically well-differentiated melanocytic neoplasms that involved the mucous membranes of the lips and oral cavity. The patients received no adjunct therapy. Sixty one of 64 dogs (95%) were alive at the end of the study or had died of causes unrelated to the tumor, with a mean survival of 23.4 months and a median survival of 34 months after surgery. Twenty-eight dogs alive at the end of the study had a mean survival of 31.3 months after surgery. There were 2 dogs, which had recurrent tumors, that were still alive at the end of the study. All dogs that died of tumor-related causes (3) and all dogs with recurrent tumors (2) had tumors in the oral cavity. Results of this study indicate that a favorable clinical course and prolonged survival can be expected in most dogs with histologically well-differentiated melanocytic neoplasms of the mucous membranes of the lips and oral cavity, with only local excision of the lesions and no adjunct therapy.

Entities:  

Mesh:

Year:  2008        PMID: 18984791     DOI: 10.1354/vp.45-6-889

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  13 in total

1.  Cell proliferation and expression of connexins differ in melanotic and amelanotic canine oral melanomas.

Authors:  Tarso Felipe Teixeira; Luciana Boffoni Gentile; Tereza Cristina da Silva; Gregory Mennecier; Lucas Martins Chaible; Bruno Cogliati; Marco Antonio Leon Roman; Marco Antonio Gioso; Maria Lucia Zaidan Dagli
Journal:  Vet Res Commun       Date:  2013-10-15       Impact factor: 2.459

Review 2.  Treatment of Canine Oral Melanomas: A Critical Review of the Literature.

Authors:  Paolo Pazzi; Gerhard Steenkamp; Anouska J Rixon
Journal:  Vet Sci       Date:  2022-04-19

3.  Expression of leptin and iNOS in oral melanomas in dogs.

Authors:  V R Greene; H Wilson; C Pfent; J Roethele; J Carwile; Y Qin; E Grimm; J A Ellerhorst
Journal:  J Vet Intern Med       Date:  2013-08-26       Impact factor: 3.333

4.  Sporadic naturally occurring melanoma in dogs as a preclinical model for human melanoma.

Authors:  R Mark Simpson; Boris C Bastian; Helen T Michael; Joshua D Webster; Manju L Prasad; Catherine M Conway; Victor M Prieto; Joy M Gary; Michael H Goldschmidt; D Glen Esplin; Rebecca C Smedley; Adriano Piris; Donald J Meuten; Matti Kiupel; Chyi-Chia R Lee; Jerrold M Ward; Jennifer E Dwyer; Barbara J Davis; Miriam R Anver; Alfredo A Molinolo; Shelley B Hoover; Jaime Rodriguez-Canales; Stephen M Hewitt
Journal:  Pigment Cell Melanoma Res       Date:  2013-11-21       Impact factor: 4.693

5.  Inhibitory Effects of a Reengineered Anthrax Toxin on Canine Oral Mucosal Melanomas.

Authors:  Adriana Tomoko Nishiya; Marcia Kazumi Nagamine; Ivone Izabel Mackowiak da Fonseca; Andrea Caringi Miraldo; Nayra Villar Scattone; José Luiz Guerra; José Guilherme Xavier; Mário Santos; Cristina Oliveira Massoco de Salles Gomes; Jerrold Michael Ward; Shihui Liu; Stephen Howard Leppla; Thomas Henrik Bugge; Maria Lucia Zaidan Dagli
Journal:  Toxins (Basel)       Date:  2020-03-02       Impact factor: 4.546

6.  Molecular and Immunohistochemical Expression of LTA4H and FXR1 in Canine Oral Melanoma.

Authors:  Laura Nordio; Chiara Bazzocchi; Francesca Genova; Valentina Serra; Maria Longeri; Giovanni Franzo; Marco Rondena; Damiano Stefanello; Chiara Giudice
Journal:  Front Vet Sci       Date:  2021-12-13

7.  Prolongation of survival of dogs with oral malignant melanoma treated by en bloc surgical resection and adjuvant CSPG4-antigen electrovaccination.

Authors:  L A Piras; F Riccardo; S Iussich; L Maniscalco; F Gattino; M Martano; E Morello; S Lorda Mayayo; V Rolih; F Garavaglia; R De Maria; E Lardone; F Collivignarelli; D Mignacca; D Giacobino; S Ferrone; F Cavallo; P Buracco
Journal:  Vet Comp Oncol       Date:  2016-05-04       Impact factor: 2.613

8.  Breed-predispositions to cancer in pedigree dogs.

Authors:  Jane M Dobson
Journal:  ISRN Vet Sci       Date:  2013-01-17

9.  Synergistic targeted inhibition of MEK and dual PI3K/mTOR diminishes viability and inhibits tumor growth of canine melanoma underscoring its utility as a preclinical model for human mucosal melanoma.

Authors:  Bih-Rong Wei; Helen T Michael; Charles H C Halsey; Cody J Peer; Amit Adhikari; Jennifer E Dwyer; Shelley B Hoover; Rajaa El Meskini; Serguei Kozlov; Zoe Weaver Ohler; William D Figg; Glenn Merlino; R Mark Simpson
Journal:  Pigment Cell Melanoma Res       Date:  2016-09-22       Impact factor: 4.693

Review 10.  Comparative Aspects of Canine Melanoma.

Authors:  Adriana Tomoko Nishiya; Cristina Oliveira Massoco; Claudia Ronca Felizzola; Eduardo Perlmann; Karen Batschinski; Marcello Vannucci Tedardi; Jéssica Soares Garcia; Priscila Pedra Mendonça; Tarso Felipe Teixeira; Maria Lucia Zaidan Dagli
Journal:  Vet Sci       Date:  2016-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.